Ian Karp | VP, Investor and Public Relations |
Michael Kauffman | CEO |
John Demaree | Chief Commercial Officer |
Mike Mason | CFO |
Perry Monaco | SVP, Sales |
Chris Primiano | Chief Business Officer and General Counsel |
Sharon Shacham | President and Chief Scientific Officer |
Maury Raycroft | Jefferies |
Brian Abrahams | RBC Capital Markets |
Peter Lawson | Barclays |
Jonathan Chang | SVB Leerink Partners LLC |
Mike Ulz | Baird |
Arlinda Lee | Canaccord |
Ed White | H.C. Wainwright |
Good morning. My name is Patrice, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics' First Quarter 2020 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.